echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > November-December Nature magazine had to look at the heavyweight highlights study

    November-December Nature magazine had to look at the heavyweight highlights study

    • Last Update: 2021-01-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    FAT1 is one of the most common mutation-driven genes in many cancers in humans.
    the loss of function of the gene has shown that FAT1 has anti-cancer effects and can prevent the production of cancer.
    , despite the high frequency of FAT1 mutations, little is known about its role in cancer.
    In a new study, researchers led by Professor Cedric Blanpain, director of the Stem Cell and Cancer Laboratory at the Free University of Brussels in Belgium, have confirmed for the first time that the absence of FAT1 promotes EMT, immersion characteristics and metastasis in skin squamous cell carcinoma (the second most common cancer in humans), lung cancer (the deadliest cancer) and head and neck tumors.
    the findings were published in the journal Nature.
    : For the first time, doi:10.1038/s41586-020-3034-x organs (organoids) are laboratory-cultured stem cells derived from similar organ tissues, often referred to as micro organs.
    they can simulate the structure and function of human organs, they are thought to be constructed
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.